Trial · NCT03937219
Participant flow14
How many started, completed or left each group, period by period.
1 to 14 of 14
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Cabozantinib + Nivolumab + Ipilimumab | 428 | |
| Overall Study | STARTED | Placebo + Nivolumab + Ipilimumab | 427 | |
| Overall Study | Received at Least 1 Dose of Study Drug | Cabozantinib + Nivolumab + Ipilimumab | 426 | |
| Overall Study | Received at Least 1 Dose of Study Drug | Placebo + Nivolumab + Ipilimumab | 423 | |
| Overall Study | Progression Free Survival (PFS) Intent-to-Treat (PITT) Population | Cabozantinib + Nivolumab + Ipilimumab | 276 | |
| Overall Study | Progression Free Survival (PFS) Intent-to-Treat (PITT) Population | Placebo + Nivolumab + Ipilimumab | 274 | |
| Overall Study | Safety Analysis Set | Cabozantinib + Nivolumab + Ipilimumab | 426 | |
| Overall Study | Safety Analysis Set | Placebo + Nivolumab + Ipilimumab | 423 | |
| Overall Study | Intent to Treat (ITT) Population | Cabozantinib + Nivolumab + Ipilimumab | 428 | |
| Overall Study | Intent to Treat (ITT) Population | Placebo + Nivolumab + Ipilimumab | 427 | |
| Overall Study | COMPLETED | Cabozantinib + Nivolumab + Ipilimumab | 185 | |
| Overall Study | COMPLETED | Placebo + Nivolumab + Ipilimumab | 187 | |
| Overall Study | NOT COMPLETED | Cabozantinib + Nivolumab + Ipilimumab | 243 | |
| Overall Study | NOT COMPLETED | Placebo + Nivolumab + Ipilimumab | 240 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03937219/flow